We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Antisoma | LSE:ASM | London | Ordinary Share | GB0055696032 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.325 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
31/1/2011 19:58 | Don't forget there are also 4 further payments of $1m from sanofi-aventis to come | newswseller | |
31/1/2011 19:54 | BB if your going to be basing your numbers on the latest report then you must use the cash present at that time which was £32.1m, rather than cash as of today £23.4m, naughty | newswseller | |
31/1/2011 19:40 | Net payables at 30 June 2010 -£8.2m including provisions Leaves £15.2m net cash at Dec 2010 (2.4p per share) Restructuring expenditure potentially -£3-4m Leaves £11-12m cash for Q1 2011 (1.8p per share) Say they reduce cash burn by half, from -£9m in H2 2010 to -£4.5m in H1 2011 Leaves £7m cash at June 2011 (1.1p per share, falling to 0.4p by year end) Cash down to zero in 14-15 months time | bookiebuster | |
31/1/2011 19:02 | The difficulty is that they need to move fairly swiftly to strip out costs but in doing so will have to spend a good chunk of cash in severance pay etc. I would certainly not be buying ASM now in the hope of a bounce but do wish holders here all the bet. | mike111d | |
31/1/2011 18:49 | BUST by Xmas. | drbrownhatter | |
31/1/2011 17:55 | A tick up at the close but I think there is more to come tomorrow...... | ajmace | |
31/1/2011 15:27 | Oh those brokers Date Broker name 13-Oct-10 Evolution Buy 01-Apr-10 ING Barings Hold 18-Feb-10 Charles Stanley Buy 11-Sep-09 Peel Hunt Buy 18-Nov-08 Seymour Pierce Buy | zulu001 | |
31/1/2011 15:21 | 'At this price, whatever happens, you still get 4p...So why not to buy I dont understand?' shutting down costs?? As others say, shareholders may get 2p or less I see very little scope for any upside | the_doctor2 | |
31/1/2011 15:07 | gdasinv2 - 31 Jan'11 - 14:59 - 5464 of 5468 At this price, whatever happens, you still get 4p...So why not to buy I dont understand? Where does it say you still get 4p. I think ive missed that bit. | robandkerry | |
31/1/2011 15:07 | Are these guys for real. No downside at 2p how about 1p or even 0p | clubman | |
31/1/2011 15:03 | How much are those men/women in the white coats earning?... | diku | |
31/1/2011 15:01 | I agree, glasinv, there isn't a downside at 2.1p. The upside is 4p as you say. | ajmace | |
31/1/2011 14:59 | At this price, whatever happens, you still get 4p...So why not to buy I dont understand? From the lession and in the cash in hand, they can plan new startgey abd price can move. I dont see any risk at this price at all. | gdasinv2 | |
31/1/2011 14:44 | How do you know how much they owe as at today. Many Company's trade on the knife edge of true insolvancy. Want to make a killing Doc. Autonomy results Tuesday big fall expected go short today. | clubman | |
31/1/2011 14:39 | agreed - very different from 'insolvent' though | the_doctor2 | |
31/1/2011 14:38 | Sad but true. Finished now. | clubman | |
31/1/2011 14:37 | That about sums it up Clubman. | robandkerry | |
31/1/2011 14:36 | Survival doubts over Antisoma as cancer drug proves a failure Rosamund Urwin "THE Drugs Don't Work," was the miserable message which sent Antisoma's shares plunging 65% today. It has stopped development of a leukaemia treatment after unsuccessful end-stage trials. This prompted Peel Hunt analyst Paul Cuddon to question whether Antisoma can survive. "Other than 3.5p of cash, which we anticipate will fall to 2p, little value remains in Antisoma, and sadly we fail to see an ongoing future," he warned. The company has halted trials for a second leukaemia drug to preserve cash and plans to slash spending. | clubman | |
31/1/2011 14:13 | Thanks Flojo,much appreciated. | duncandisorderly | |
31/1/2011 14:12 | 632.46 Million | flojo | |
31/1/2011 14:10 | Sorry guys,does anyone know how many shares there are with asm? | duncandisorderly | |
31/1/2011 14:03 | I'm not invested, no. I wasnt before either of the PIII failures. however, ASM has cash for now, so it's just plain idiotic to suggest it's insolvent. That doesnt mean I think it's a good investment. It isnt. Although buyers here could see a small return in a buyout - but may not | the_doctor2 | |
31/1/2011 13:59 | Will be gobbled up for a pittance. | clubman |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions